NEW YORK (GenomeWeb) – Empire Genomics said on Monday that it has acquired molecular diagnostic reagents firm ID Labs for an undisclosed amount.
Based in London, Ontario, ID Labs provides antibodies, molecular probes, cytogenetics media, and other molecular biology reagents to academia, government, pharmaceutical, biotech, and hospital customers.
Empire Genomics CEO Anthony Johnson said that the deal is aligned "with our corporate strategy of complementing the product offerings for our clinical lab and customers, as well as increasing our global distribution network." He added that he expects it to be the first of several acquisitions "as we look to accelerate the growth of our business in the ever changing molecular diagnostics environment."